Stage IIIB Breast Cancer AJCC v7 Recruiting Phase 1 Trials for Entinostat (DB11841)

IndicationStatusPhase
DBCOND0092287 (Stage IIIB Breast Cancer AJCC v7)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02453620Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast CancerTreatment